Evidence map›Paper›PMID 29941017›Full record

ArticleVeterinary research2018

A Mycobacterium avium subsp. paratuberculosis relA deletion mutant and a 35 kDa major membrane protein elicit development of cytotoxic T lymphocytes with ability to kill intracellular bacteria.

Gaber S Abdellrazeq, Mahmoud M Elnaggar, John P Bannantine, Kun T Park, Cleverson D Souza, Brian Backer, Victoria Hulubei, Lindsay M Fry, Samy A Khaliel, Helmy A Torky and 2 more

Open access · goldAbstract read
In one paragraph

Article in Veterinary research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Frontiers in immunology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Evaluation ofFrontiers in cellular and infection microbiology · 2023
    Article
  7. Article
  8. Frontiers in veterinary science · 2022
    Review
  9. Review
  10. Metabolites · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Bovine DerivedFrontiers in immunology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Gaber S AbdellrazeqDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA, USA.
Mahmoud M ElnaggarDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA, USA.
John P BannantineUSDA, ARS, National Animal Disease Center, Ames, IA, USA.
Kun T ParkDepartment of Biotechnology, Inje University, Injero 197, Kimhae-si, Gimhae, Gyeongsangnam-do, South Korea.
Cleverson D SouzaDepartment of Veterinary Clinical Sciences, Washington State University, Pullman, WA, USA.
Brian BackerDepartment of Chemistry, College of Arts and Sciences, Washington State University, Pullman, WA, USA.
Victoria HulubeiDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA, USA.
Lindsay M FryUSDA, ARS, Animal Disease Research Unit, Pullman, WA, USA.
Samy A KhalielDepartment of Microbiology, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt.
Helmy A TorkyDepartment of Microbiology, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt.
David A SchneiderDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA, USA.
William C DavisDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA, USA. davisw@wsu.edu.
Washington State University · USAlexandria University · EGInje University · KRNational Animal Disease Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efforts to develop live attenuated vaccines against Mycobacterium avium subspecies paratuberculosis (Map), using indirect methods to screen Map deletion mutants for potential efficacy, have not been successful. A reduction in the capacity to survive in macrophages has not predicted the ability of mutants to survive in vivo. Previous studies for screening of three deletion mutants in cattle and goats revealed one mutant, with a deletion in relA (ΔMap/relA), could not establish a persistent infection. Further studies, using antigen presenting cells (APC), blood dendritic cells and monocyte derived DC, pulsed with ΔMap/relA or a 35 kDa Map membrane protein (MMP) revealed a component of the response to ΔMap/relA was directed towards MMP. As reported herein, we developed a bacterium viability assay and cell culture assays for analysis and evaluation of cytotoxic T cells generated against ΔMap/relA or MMP. Analysis of the effector activity of responding cells revealed the reason ΔMap/relA could not establish a persistent infection was that vaccination elicited development of cytotoxic CD8 T cells (CTL) with the capacity to kill intracellular bacteria. We demonstrated the same CTL response could be elicited with two rounds of antigenic stimulation of APC pulsed with ΔMap/relA or MMP ex vivo. Cytotoxicity was mediated through the perforin granzyme B pathway. Finally, cognate recognition of peptides presented in context of MHC I and II molecules to CD4 and CD8 T cells is required for development of CTL.

Indexed as

AnimalsBacterial ProteinsBase SequenceCattleMaleMembrane ProteinsMicrobial ViabilityMycobacterium avium subsp. paratuberculosisSequence DeletionT-Lymphocytes, CytotoxicVaccines, AttenuatedBacterial ProteinsMembrane ProteinsVaccines, Attenuated

Identifiers

PMID29941017
PMCPMC6019527
OpenAlexW2810561776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.